e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Clinical management of orphan lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long term administration of anti-TNFalpha in ankylosing spondylitis (AS) patients – A post-hoc analysis
C. Mandros, D. Ntelios, I. Tassiou, P. Malindretos, E. Potolidis, G. Tzelepis (Volos, Athens, Greece)
Source:
Annual Congress 2013 –Clinical management of orphan lung diseases
Session:
Clinical management of orphan lung diseases
Session type:
Oral Presentation
Number:
1799
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Mandros, D. Ntelios, I. Tassiou, P. Malindretos, E. Potolidis, G. Tzelepis (Volos, Athens, Greece). Long term administration of anti-TNFalpha in ankylosing spondylitis (AS) patients – A post-hoc analysis. Eur Respir J 2013; 42: Suppl. 57, 1799
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Related content which might interest you:
Evaluation of lungs in ankylosing spondylitis patients
Source: Annual Congress 2009 - Old and new: technique and pathology
Year: 2009
Use of home non-invasive ventilation (NIV) in patients with ankylosing spondylitis (AS)
Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts
Year: 2012
Evaluation of respiratory impedance in patients with ankylosing spondylitis
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020
Does CTLA-4 and CD-28 polymorphism affect the lung involvement in Turkish ankylosing spondylitis patients??
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Rehabilitation of pulmonary dysfunction in patients with ankylosing spondylitis
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011
Patient with ankylosing spondylitis and pulmonary hypertension
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020
Adalimumab and etanercept induced asthma
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Clinical characteristics and outcomes of elderly patients with COPD: TIOSPIR® post-hoc analysis
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Short term glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: "REDUCE*", a non-inferiority multicenter trial. (*
Red
uction in the
U
se of
C
orticosteroids in
E
xacerbated COPD; ISRCTN19646069)
Source: Annual Congress 2012 - Acute exacerbation in COPD
Year: 2012
Anti-depressants in severe and brittle asthma patients on long term corticosteroids: An observational study
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Pulmonary hypertension in ankylosing spondylitis
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004
Characteristics of severe asthmatics treated with omalizumab, mepolizumab or no biotherapy. Data from the Belgian Severe Asthma Registry (BSAR).
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019
Development and improvement of single-stage surgical treatments of patients with spondylitis and pulmonary and pleural TB
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016
Rate of occurrence of lung function testing abnormalities in Greek ankylosing spondylitis patients
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013
Cluster analyses in a sample of COPD patients
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 1
Year: 2014
Effect of inhaled steroid therapy on treatment response in hosptalized pneumonia patients: Results from Turkish Thoracic Society database
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Effect of tocilizumab on interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA)
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020
30 years experience of plasmapheresis using in complex treatment of pulmonary sarcoidosis (PS)
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Evaluation of methotrexate in the treatment of severe asthma
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept